Consensus $4.91.
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on RVTY:
- The Week That Was, The Week Ahead: Macro and Markets, Jan. 11
- Revvity announces collaboration with Eli Lilly on AI drug discovery models
- Revvity price target raised to $112 from $108 at Evercore ISI
- OpenAI spoke to Revvity about licensing data, The Information reports
- Revvity price target raised to $107 from $102 at Wells Fargo